UthPeak™ NMNH: 5 Years Younger Clinically Proven

Overview


Effepharm

NMNH, the reduced form of NMN, is a potent NAD+ precursor.

UthPeak™ reduced NMN (NMNH), the world’s first Self-GRAS approved, US patent-pending reduced NMN, completed the first, largest and longest Phase I clinical trial, demonstrating a remarkable 5-year age reversal validated by UCLA’s epigenetic study in “Aging” the global golden standard for measuring biological age.

Highlights of the clinical trial are:

● NAD+ Levels: Increased by 3 times

● Biological Age: Reduced by an average of 5 years

● Energy Levels: Enhanced by 35%

● Emotional Health: Improved by 31%

Contact us for more clinical study details.

This content is provided by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

Your Product Innovation Begins Here: Booth 4555

Your Product Innovation Begins Here: Booth 4555

Content provided by Effepharm Ltd

Product Brochure

EffePharm will showcase innovative anti-aging solutions, including UthPeak™ reduced NMN (NMNH), the first Self-GRAS approved, US patent-pending reduced NMN.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.